Laboratory of Molecular Medicine, Department of Clinical Immunology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, DK 2100 Copenhagen, Denmark.
J Biol Chem. 2012 Sep 21;287(39):32913-21. doi: 10.1074/jbc.M112.386680. Epub 2012 Aug 1.
The human lectin complement pathway activation molecules comprise mannose-binding lectin (MBL) and ficolin-1, -2, and -3 in complex with associated serine proteases MASP-1, -2, and -3 and the non-enzymatic small MBL associated protein or sMAP. Recently, a novel plasma protein named MBL/ficolin-associated protein-1 (MAP-1) was identified in humans. This protein is the result of a differential splicing of the MASP1 gene and includes the major part of the heavy chain but lacks the serine protease domain. We investigated the direct interactions of MAP-1 and MASP-3 with ficolin-3 and MBL using surface plasmon resonance and found affinities around 5 nm and 2.5 nm, respectively. We studied structural aspects of MAP-1 and could show by multi-angle laser light scattering that MAP-1 forms a calcium-dependent homodimer in solution. We were able to determine the crystal structure of MAP-1, which also contains a head-to-tail dimer ∼146 Å long. This structure of MAP-1 also enables modeling and assembly of the MASP-1 molecule in its entirety. Finally we found that MAP-1 competes with all three MASPs for ligand binding and is able to mediate a strong dose-dependent inhibitory effect on the lectin pathway activation, as measured by levels of C3 and C9.
人凝集素补体途径激活分子包括甘露聚糖结合凝集素(MBL)和纤维胶凝素-1、-2 和-3 与相关丝氨酸蛋白酶 MASP-1、-2 和-3 以及非酶小 MBL 相关蛋白或 sMAP 形成复合物。最近,在人类中发现了一种名为 MBL/纤维胶凝素相关蛋白-1(MAP-1)的新型血浆蛋白。该蛋白是 MASP1 基因差异剪接的结果,包含重链的大部分,但缺乏丝氨酸蛋白酶结构域。我们使用表面等离子体共振技术研究了 MAP-1 和 MASP-3 与纤维胶凝素-3 和 MBL 的直接相互作用,发现亲和力分别约为 5nm 和 2.5nm。我们研究了 MAP-1 的结构方面,并通过多角度激光散射表明,MAP-1 在溶液中形成依赖钙的同源二聚体。我们能够确定 MAP-1 的晶体结构,该结构还包含一个约 146Å 长的从头至尾二聚体。该 MAP-1 结构还允许对完整的 MASP-1 分子进行建模和组装。最后,我们发现 MAP-1 与所有三种 MASP 竞争配体结合,并能够在凝集素途径激活的水平上介导强烈的剂量依赖性抑制作用,如 C3 和 C9 的水平所示。